|
Population
|
Humans
|
Animals/Plants
|
|
All ages/sexes
| |
|
Individuals in FCASa
| |
|
Refugees or migrants in LMICa
| |
|
Intervention/Exposure
|
Infections/colonization with an antibiotic resistant organism (Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacteriaceae (Escherichia coli and/or Klebsiella pneumonia), and/or Staphylococcus aureus)
|
Tuberculosis
|
|
Comparator
|
Susceptible infections/colonization or absence of infection/colonization
| |
|
Outcomes
|
Associated health burden (mortality, morbidity …)
|
Molecular biology only
|
|
All economic perspectives
| |
|
Associated healthcare cost burden, direct costs (resource use, opportunity cost …)
|
Epidemiology only
|
|
Indirect costs (loss of productivity …)
| |
|
Intangible costs (decreased quality of life …)
| |
|
Study design
|
Case-control studies
|
Conference abstracts
|
|
Cohort studies
|
Posters
|
|
Cross-sectional studies
|
Systematic reviews
|
|
Randomised controlled studies
| |
|
Modelling studies
| |
|
Economic evaluations
| |
